Azelastine hydrochloride

This classification denotes a histamine-1 receptor antagonist with the molecular formula C22H24ClN3O.ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 0L591QR10I, chemically known as 1(2h)-phthalazinone, 4-((4-chlorophenyl)methyl)-2-(hexahydro-1-methyl-1h-azepin-4-yl)-, monohydrochloride but more generally known as azelastine hydrochloride, which bears US NIH Compound Identifier 54360. European Medicines Agency schedules Azelastine hydrochloride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB00642MIG. Most nations, for tariff and trade purposes, schedule azelastine hydrochloride under HS 29339930 and SITC 51577. As of Q4 2014, AZELASTINE HYDROCHLORIDE remains US FDA's Preferred Term for this commodity. Azelastine hydrochloride bears US NLM identifiers UMLS ID C0771004 and NCI Concept Code C47408. SMILES: CN1CCCC(CC1)N2C(=O)C3CCCCC3C(N2)CC4CCC(CC4)CL.CL.